1. What are microRNAs, and how do they function in post-transcriptional gene regulation?
Answer:
Definition: MicroRNAs (miRNAs) are small, non-coding RNAs, typically 20-24 nucleotides long, that regulate gene expression post-transcriptionally.
Function:
- Transcription and Processing:
- miRNAs are transcribed as primary transcripts (pri-miRNAs) by RNA polymerase II or III.
- Pri-miRNAs are processed in the nucleus by Drosha and DGCR8 into precursor miRNAs (pre-miRNAs).
- Export and Maturation:
- Pre-miRNAs are exported to the cytoplasm by Exportin-5 and further processed by Dicer into mature miRNA duplexes.
- Target Regulation:
- Mature miRNAs are incorporated into the RNA-induced silencing complex (RISC), where they guide the complex to complementary target mRNAs, leading to either degradation or translational repression.
2. Discuss the biogenesis pathway of microRNAs.
Answer:
Biogenesis Pathway:
- Transcription:
- miRNAs are transcribed from miRNA genes as pri-miRNAs by RNA polymerase II or III.
- Nuclear Processing:
- Pri-miRNAs are cleaved by the Drosha-DGCR8 complex to form pre-miRNAs (~70 nucleotides long).
- Export to Cytoplasm:
- Pre-miRNAs are exported via Exportin-5 and Ran-GTP.
- Cytoplasmic Processing:
- Dicer cleaves pre-miRNAs into mature miRNA duplexes (~22 nucleotides).
- RISC Loading:
- The guide strand of the duplex is incorporated into RISC, where it directs the complex to target mRNAs.
3. Explain the role of the Drosha-DGCR8 complex in miRNA processing.
Answer:
- Location: Found in the nucleus.
- Function: Processes primary miRNAs (pri-miRNAs) into precursor miRNAs (pre-miRNAs).
- Mechanism:
- Drosha, an RNase III enzyme, cleaves the pri-miRNA at specific sites.
- DGCR8 acts as a cofactor, recognizing the hairpin structure of pri-miRNAs.
This step is essential for generating pre-miRNAs for further cytoplasmic processing.
4. What is the significance of Dicer in miRNA maturation?
Answer:
- Role: Dicer is a cytoplasmic RNase III enzyme crucial for converting pre-miRNAs into mature miRNA duplexes.
- Mechanism:
- It recognizes the loop structure of pre-miRNAs and cleaves them into ~22-nucleotide duplexes.
- One strand (the guide strand) is incorporated into RISC, while the passenger strand is degraded.
5. How do miRNAs identify their target mRNAs?
Answer:
- Mechanism: miRNAs recognize target mRNAs through sequence complementarity between their seed region (nucleotides 2-8 of the miRNA) and the target’s 3′ untranslated region (3′ UTR).
- Outcome: Depending on the degree of complementarity, miRNAs either:
- Induce mRNA degradation (perfect match).
- Suppress translation (partial match).
6. Discuss the role of Argonaute proteins in miRNA function.
Answer:
- Role in RISC: Argonaute proteins are the core components of the RNA-induced silencing complex (RISC).
- Functions:
- Bind to the guide strand of miRNA.
- Facilitate target mRNA recognition and cleavage (for perfect matches).
- Inhibit translation by stalling ribosomes (for imperfect matches).
7. Describe the dual regulatory role of miRNAs in cancer.
Answer:
- Tumor Suppressors:
- miRNAs downregulate oncogenes. For example, let-7 targets RAS oncogene mRNA.
- Oncogenes:
- miRNAs, like miR-21, suppress tumor suppressor genes, leading to cancer progression.
- Therapeutic Implications: Understanding miRNA dysregulation offers opportunities for targeted cancer therapies.
8. Explain the seed region of miRNAs and its significance in target recognition.
Answer:
- Definition: The seed region is a conserved 7-8 nucleotide sequence at the 5′ end of miRNAs.
- Significance:
- Critical for binding target mRNAs.
- Determines specificity of target recognition.
- Mutations in the seed region can alter miRNA function and lead to diseases.
9. How do miRNAs regulate gene expression in plants and animals?
Answer:
- In Animals:
- Bind to 3′ UTR of mRNAs, leading to translational repression or mRNA degradation.
- In Plants:
- Bind with near-perfect complementarity to mRNA coding regions, causing direct cleavage of target mRNAs.
10. Discuss the clinical significance of miRNAs in neurodegenerative diseases.
Answer:
- Roles:
- miRNA dysregulation contributes to Alzheimer’s, Parkinson’s, and Huntington’s diseases.
- For example, miR-29 is implicated in preventing amyloid-beta plaque formation in Alzheimer’s.
- Potential Therapies: miRNA-based treatments could restore normal gene expression.
11. How are miRNAs involved in developmental biology?
Answer:
- Functions:
- Regulate genes involved in cell differentiation, proliferation, and apoptosis.
- For example, miR-430 in zebrafish clears maternal mRNAs during embryogenesis.
12. What are the therapeutic applications of miRNAs?
Answer:
- Applications:
- miRNA Mimics: Restore lost miRNA function in diseases.
- miRNA Inhibitors: Block overactive miRNAs.
- Cancer Therapy: Target oncogenic miRNAs.
13. Describe the methods used to study miRNA functions.
Answer:
- Techniques:
- Microarray and RNA sequencing to identify miRNA expression profiles.
- Luciferase reporter assays to validate miRNA-mRNA interactions.
- CRISPR/Cas9 to knock out miRNA genes.
14. What is the role of miRNAs in stem cell differentiation?
Answer:
- miRNAs, like miR-145, regulate the balance between self-renewal and differentiation in stem cells by targeting pluripotency genes like OCT4 and SOX2.
15. How does Exportin-5 facilitate miRNA processing?
Answer:
- Exportin-5 recognizes pre-miRNAs in the nucleus and transports them to the cytoplasm using Ran-GTP as an energy source.
16. Discuss the relationship between miRNAs and metabolic disorders.
Answer:
- Dysregulated miRNAs, like miR-33, affect lipid metabolism, insulin sensitivity, and obesity, contributing to metabolic diseases.
17. What are circular RNAs (circRNAs), and how do they interact with miRNAs?
Answer:
- CircRNAs act as miRNA sponges, sequestering miRNAs and preventing them from binding to their target mRNAs.
18. Explain the concept of miRNA sponges in gene regulation.
Answer:
- miRNA sponges are RNA molecules that bind miRNAs, reducing their availability to target mRNAs, thereby modulating gene expression.
19. What challenges are associated with miRNA-based therapies?
Answer:
- Challenges:
- Delivery of miRNAs to specific tissues.
- Off-target effects.
- Stability of miRNAs in vivo.
20. How does miRNA dysregulation lead to immune system disorders?
Answer:
- Dysregulated miRNAs, such as miR-155, alter cytokine production and immune cell differentiation, leading to autoimmune diseases like lupus.